Society For Neuro Oncology
EIN: 760499664 · Houston, TX · NTEE: A20Z
Is Society For Neuro Oncology Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Society For Neuro Oncology
Society For Neuro Oncology (EIN: 760499664) is a nonprofit organization based in Houston, TX, classified under NTEE code A20Z. The organization reported total revenue of $5.9M and total assets of $7.6M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Society For Neuro Oncology's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Society For Neuro Oncology is a mid-size nonprofit that has been operating for 29 years, with 12 years of IRS 990 filings on record (2011–2022). Revenue has grown at a compound annual rate of 8.4%.
Key Financial Metrics (2022)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.9M |
| Total Expenses | $4.4M |
| Surplus / Deficit | $-489,530 |
| Total Assets | $6.4M |
| Total Liabilities | $306K |
| Net Assets | $6.1M |
| Operating Margin | -12.7% |
| Debt-to-Asset Ratio | 4.8% |
| Months of Reserves | 17.7 months |
Financial Health Grade: B
In 2022, Society For Neuro Oncology reported a deficit of $490K with expenses exceeding revenue, holds 17.7 months of operating reserves (strong position), has a debt-to-asset ratio of 4.8% (very low leverage).
Financial Trends
Over 12 years of filings (2011–2022), Society For Neuro Oncology's revenue has grown at a compound annual growth rate (CAGR) of 8.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2022 | -1.2% | +102.3% | -7.0% |
| 2021 | -2.0% | -49.7% | +31.8% |
| 2020 | -17.5% | -5.1% | -5.1% |
| 2019 | +11.6% | +17.0% | +0.6% |
| 2018 | +15.5% | +25.0% | +21.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1997 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Society For Neuro Oncology has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Society For Neuro Oncology with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2022)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $490K, with expenses exceeding revenue.
- Debt-to-asset ratio: 4.8%.
Frequently Asked Questions about Society For Neuro Oncology
Is Society For Neuro Oncology a legitimate charity?
Based on AI analysis of IRS 990 filings, Society For Neuro Oncology (EIN: 760499664) insufficient data. 0 red flags identified, 0 strengths noted.
How does Society For Neuro Oncology spend its money?
Detailed spending breakdown data is not yet available for Society For Neuro Oncology. Check back for updated IRS 990 analysis.
Are donations to Society For Neuro Oncology tax-deductible?
Society For Neuro Oncology is registered as a tax-exempt nonprofit (EIN: 760499664). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Filing History
IRS 990 filing history for Society For Neuro Oncology showing financial trends over 12 years of public records:
Over 12 years of IRS 990 filings (2011–2022), Society For Neuro Oncology's revenue has grown by 142.1%, moving from $1.6M to $3.9M. Total assets increased by 295.5% over the same period, from $1.6M to $6.4M. Total functional expenses rose by 243.6%, from $1.3M to $4.4M. In its most recent filing year (2022), Society For Neuro Oncology reported a deficit of $490K, with expenses exceeding revenue. The organization holds $306K in liabilities against $6.4M in assets (debt-to-asset ratio: 4.8%), resulting in net assets of $6.1M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2022 | $3.9M | $4.4M | $6.4M | $306K | — | View 990 |
| 2021 | $3.9M | $2.2M | $6.9M | $298K | — | — |
| 2020 | $4.0M | $4.3M | $5.2M | $393K | — | — |
| 2019 | $4.8M | $4.5M | $5.5M | $394K | — | View 990 |
| 2018 | $4.3M | $3.9M | $5.5M | $693K | — | View 990 |
| 2017 | $3.8M | $3.1M | $4.5M | $214K | — | View 990 |
| 2016 | $3.5M | $2.8M | $4.0M | $407K | — | View 990 |
| 2015 | $2.9M | $2.5M | $3.5M | $569K | — | View 990 |
| 2014 | $2.3M | $2.0M | $3.0M | $464K | — | View 990 |
| 2013 | $2.1M | $1.9M | $2.4M | $229K | — | View 990 |
| 2012 | $1.8M | $1.4M | $2.0M | $257K | — | View 990 |
| 2011 | $1.6M | $1.3M | $1.6M | $309K | — | View 990 |
Year-by-Year Financial Summary
- 2022: Revenue of $3.9M, expenses of $4.4M, and assets of $6.4M (revenue -1.2% year-over-year).
- 2021: Revenue of $3.9M, expenses of $2.2M, and assets of $6.9M (revenue -2.0% year-over-year).
- 2020: Revenue of $4.0M, expenses of $4.3M, and assets of $5.2M (revenue -17.5% year-over-year).
- 2019: Revenue of $4.8M, expenses of $4.5M, and assets of $5.5M (revenue +11.6% year-over-year).
- 2018: Revenue of $4.3M, expenses of $3.9M, and assets of $5.5M (revenue +15.5% year-over-year).
- 2017: Revenue of $3.8M, expenses of $3.1M, and assets of $4.5M (revenue +7.0% year-over-year).
- 2016: Revenue of $3.5M, expenses of $2.8M, and assets of $4.0M (revenue +22.5% year-over-year).
- 2015: Revenue of $2.9M, expenses of $2.5M, and assets of $3.5M (revenue +23.9% year-over-year).
- 2014: Revenue of $2.3M, expenses of $2.0M, and assets of $3.0M (revenue +11.8% year-over-year).
- 2013: Revenue of $2.1M, expenses of $1.9M, and assets of $2.4M (revenue +13.9% year-over-year).
- 2012: Revenue of $1.8M, expenses of $1.4M, and assets of $2.0M (revenue +14.0% year-over-year).
- 2011: Revenue of $1.6M, expenses of $1.3M, and assets of $1.6M.
Data Sources and Methodology
This transparency report for Society For Neuro Oncology is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.